Last reviewed · How we verify
NCT03341585
Influence of Expiration Lente Prolongée on Gastro-oesophageal Reflux
NA trial testing expiration lente prolongée in Gastro-esophageal Reflux in 55 participants. Completed in 15 December 2020.
15 December 2020
Quick facts
| Lead sponsor | Vrije Universiteit Brussel |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 55 |
| Start date | 7 June 2018 |
| Primary completion | 15 December 2020 |
| Estimated completion | 15 December 2020 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- expiration lente prolongée
Conditions studied
- Gastro-esophageal Reflux — all drugs for Gastro-esophageal Reflux →
Sponsor
Vrije Universiteit Brussel — full company profile →
Who can join
Adults 1 Day to 365 Days, any sex, with Gastro-esophageal Reflux. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine whether a specific airway clearance technique, l'Expiration Lente Prolongée (ELPr), induces or aggravates gastro-oesophageal reflux in infants under the age of one year. Infants referred to hospital for a multichannel intraluminal impedance pH (pH-MII) monitoring are included in this study. Participation is only possible after signing the informal consent by one of the parents.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prolonged Slow Expiration Technique and Gastroesophageal Reflux in Infants Under the Age of 1 Year.
Lievens L, Vandenplas Y, Vanlaethem S, Van Ginderdeuren F. · · 2021 · PMID 34568241 · DOI 10.3389/fped.2021.722452
Verify or expand the search:
- PubMed search for NCT03341585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Vrije Universiteit Brussel trials
Trials by the same sponsor.
- NCT07460778 — Development of Serious Games for Rehabilitation: a Delphi Study · NA · recruiting
- NCT07359521 — Implementation and Evaluation of a Complex Intervention to Reduce Avoidable Transitions Between Nursing Home and Hospita · NA · not yet recruiting
- NCT07356336 — Cognitive Model for Behavioral Interventions as a Non-pharmacological Intervention for Behavioral and Psychological Symp · NA · recruiting
- NCT07212829 — The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pai · NA · not yet recruiting
- NCT07294131 — Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electro · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03341585 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vrije Universiteit Brussel
- Last refreshed: 17 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03341585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing